NO20084577L - Probiotisk stamme og antimikrobielle peptider fra disse - Google Patents
Probiotisk stamme og antimikrobielle peptider fra disseInfo
- Publication number
- NO20084577L NO20084577L NO20084577A NO20084577A NO20084577L NO 20084577 L NO20084577 L NO 20084577L NO 20084577 A NO20084577 A NO 20084577A NO 20084577 A NO20084577 A NO 20084577A NO 20084577 L NO20084577 L NO 20084577L
- Authority
- NO
- Norway
- Prior art keywords
- peptide
- antimicrobial
- strain
- st4sa
- mundtii
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
- A01N63/50—Isolated enzymes; Isolated proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/46—Streptococcus ; Enterococcus; Lactococcus
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Virology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biomedical Technology (AREA)
- Mycology (AREA)
- General Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Plant Pathology (AREA)
- Agronomy & Crop Science (AREA)
- Pest Control & Pesticides (AREA)
- Dentistry (AREA)
- Environmental Sciences (AREA)
- Immunology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Oppfinnelsen angår en stamme av Enterococcus mundtii som har probiotiske egenskaper. Stammen av E. mundtii (ST4SA) produserer et antimikrobielt peptid som oppviser antimikrobiell aktivitet mot et bredt spekter av bakterier. Oppfinnelsen tilveiebringer også en isolert nukleotidsekvens som koder for det antimikrobielle peptidet (peptid ST4SA). Et annet aspekt ved oppfinnelsen angår en fremgangsmåte for fremstilling av et peptid ifølge oppfinnelsen som omfatter å dyrke Enterococcus mundtii-stamme ST4SA i et næringsmedium under mikroaerofile betingelser ved en temperatur på mellom 10 °C og 45 °C, inntil en utvinnbar mengde av nevnte peptid blir produsert og utvinne nevnte peptid. Det isolerte peptidet ifølge oppfinnelsen kan anvendes som et antimikrobielt middel i en flytende formulering eller en gelformulering som en topisk behandling og kan også anvendes som et antimikrobielt middel etter innkapsling i en polymer.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ZA200604035A ZA200604035B (en) | 2005-05-31 | 2006-05-28 | Improved grenade launcher |
PCT/IB2007/051982 WO2007138538A2 (en) | 2006-05-28 | 2007-05-25 | Probiotic strain and antimicrobial peptide derived therefrom |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20084577L true NO20084577L (no) | 2008-12-19 |
Family
ID=38779065
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20084577A NO20084577L (no) | 2006-05-28 | 2008-11-03 | Probiotisk stamme og antimikrobielle peptider fra disse |
Country Status (13)
Country | Link |
---|---|
US (2) | US7951385B2 (no) |
EP (1) | EP2021457B1 (no) |
JP (1) | JP2009538614A (no) |
KR (1) | KR101521123B1 (no) |
CN (1) | CN101454440B (no) |
AP (1) | AP2841A (no) |
AU (1) | AU2007266675B2 (no) |
CA (1) | CA2647161A1 (no) |
EA (1) | EA017558B1 (no) |
IL (2) | IL195520A0 (no) |
NO (1) | NO20084577L (no) |
NZ (1) | NZ571619A (no) |
WO (1) | WO2007138538A2 (no) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101521123B1 (ko) * | 2006-05-28 | 2015-05-19 | 시플라 메드프로 리서치 앤드 디벨롭먼트 (피티와이) 엘티디 | 프로바이오틱 스트레인 및 그로부터 유도된 항균 펩티드 |
US8357519B2 (en) * | 2008-11-19 | 2013-01-22 | The Ohio State University | Methods and processes for producing esters |
WO2011045764A1 (en) * | 2009-10-15 | 2011-04-21 | Cipla Medpro Research And Development (Pty) Ltd | A product for delivering antimicrobially active substances to an infected site |
WO2012060312A1 (ja) * | 2010-11-05 | 2012-05-10 | 国立大学法人広島大学 | 籾殻または玄米から単離された植物乳酸菌およびその利用 |
US20120294924A1 (en) * | 2011-04-29 | 2012-11-22 | Thomas Tice | Peptide-Lipid Conjugates And Uses Thereof |
RU2532227C1 (ru) * | 2013-10-23 | 2014-10-27 | Федеральное бюджетное учреждение науки Государственный научный центр прикладной микробиологии и биотехнологии (ФБУН ГНЦ ПМБ) | Штамм enterоcoccus mundtii, продуцирующий субстанцию пептидной природы с антилистериозной активностью |
RU2599430C1 (ru) * | 2015-07-23 | 2016-10-10 | Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Горский государственный аграрный университет" | ШТАММ ЛАКТОБАКТЕРИЙ Enterococcus mundtii - ПРОДУЦЕНТ МОЛОЧНОЙ КИСЛОТЫ И АНТИБИОТИЧЕСКИХ ВЕЩЕСТВ |
US9944960B2 (en) * | 2015-11-17 | 2018-04-17 | Premier Research Labs, Lp | Process for microbial production of dihydrolipoic acid and extraction of dihydrolipoic acid with edible oils |
CN105385636A (zh) * | 2015-12-07 | 2016-03-09 | 江南大学 | 一株产细菌素的肠膜明串珠菌及其应用 |
JP2019510036A (ja) | 2016-03-31 | 2019-04-11 | ゴジョ・インダストリーズ・インコーポレイテッド | プロバイオティクス/プレバイオティクス有効成分を含む清浄剤組成物 |
EP3436156A1 (en) | 2016-03-31 | 2019-02-06 | Gojo Industries, Inc. | Antimicrobial peptide stimulating cleansing composition |
KR101722255B1 (ko) * | 2016-04-22 | 2017-04-03 | 주식회사 폴인브레드 | 쌀과 쌀누룩을 이용한 자연발효종 제조방법 |
JP2020500860A (ja) | 2016-11-23 | 2020-01-16 | ゴジョ・インダストリーズ・インコーポレイテッド | プロバイオティック/プレバイオティックな有効成分を含む消毒薬組成物 |
KR102636571B1 (ko) * | 2018-01-31 | 2024-02-15 | 누트리 컴퍼니 리미티드 | 폐렴구균 감염증의 예방 및/또는 치료제 |
KR102076089B1 (ko) | 2018-10-02 | 2020-02-11 | 서울대학교 산학협력단 | 니신 z 생산능이 우수한 락토코커스 락티스 서브스페시스 락티스 ldtm 6804 신균주(kctc 13564bp) |
CN109456911B (zh) * | 2018-10-10 | 2019-10-18 | 南京林业大学 | 一株蒙氏肠球菌HcM7及其应用 |
CN110846260B (zh) * | 2019-12-18 | 2021-03-02 | 江南大学 | 一株降低生物胺的肉葡萄球菌及其应用 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH1084969A (ja) | 1996-09-19 | 1998-04-07 | Chemo Sero Therapeut Res Inst | ヘモフィルス・パラガリナルム由来新規ポリペプチド及びその製法 |
US7655775B2 (en) * | 1997-09-05 | 2010-02-02 | Canbiocin, Inc. | Expression vectors for treating bacterial infections |
WO2001030818A1 (fr) | 1999-10-22 | 2001-05-03 | Shanghai Bio Road Gene Development Ltd. | Nouveau polypeptide, proteine de liaison 33 a l'arn, et polynucleotide codant pour ce polypeptide |
GB0027761D0 (en) | 2000-11-14 | 2000-12-27 | Nestle Sa | Nutritional composition for an immune condition |
DE10105347A1 (de) * | 2001-02-05 | 2002-08-22 | Nutrinova Gmbh | Sorbinsäurepräparat enthaltend Probiotika als Futtermittelzusatz in der Nutztieraufzucht |
GB0125535D0 (en) | 2001-10-24 | 2001-12-12 | Microbiological Res Authority | Mycobacterial genes down-regulated during latency |
US6878373B2 (en) | 2001-12-03 | 2005-04-12 | Micropure Technologies, Inc. | Probiotic composition containing Bacillus cereus RRRL B-30535 |
JP4111489B2 (ja) * | 2002-05-23 | 2008-07-02 | プリマハム株式会社 | 新規バクテリオシン |
AU2003211648A1 (en) * | 2002-07-03 | 2004-01-23 | Galina Gennadievna Alekhina | Probiotic compound on the basis of enterococcus faecium strain l-3 for medical-prophylactic means and method of production thereof |
EP1384483A1 (en) | 2002-07-23 | 2004-01-28 | Nestec S.A. | Probiotics for treatment of irritable bowel disease (IBS) through improvement of gut neuromuscular function |
ITBO20020564A1 (it) | 2002-09-06 | 2004-03-07 | Alfa Wassermann Spa | Bifidobatteri e preparazioni che li contengono. |
KR101521123B1 (ko) * | 2006-05-28 | 2015-05-19 | 시플라 메드프로 리서치 앤드 디벨롭먼트 (피티와이) 엘티디 | 프로바이오틱 스트레인 및 그로부터 유도된 항균 펩티드 |
-
2007
- 2007-05-25 KR KR1020087031307A patent/KR101521123B1/ko not_active IP Right Cessation
- 2007-05-25 WO PCT/IB2007/051982 patent/WO2007138538A2/en active Application Filing
- 2007-05-25 JP JP2009512739A patent/JP2009538614A/ja active Pending
- 2007-05-25 EP EP07736018.8A patent/EP2021457B1/en active Active
- 2007-05-25 CA CA002647161A patent/CA2647161A1/en not_active Abandoned
- 2007-05-25 NZ NZ571619A patent/NZ571619A/en not_active IP Right Cessation
- 2007-05-25 CN CN2007800198580A patent/CN101454440B/zh not_active Expired - Fee Related
- 2007-05-25 AU AU2007266675A patent/AU2007266675B2/en not_active Ceased
- 2007-05-25 US US12/302,067 patent/US7951385B2/en active Active
- 2007-05-25 EA EA200802409A patent/EA017558B1/ru not_active IP Right Cessation
- 2007-05-25 AP AP2008004626A patent/AP2841A/xx active
-
2008
- 2008-11-03 NO NO20084577A patent/NO20084577L/no not_active Application Discontinuation
- 2008-11-26 IL IL195520A patent/IL195520A0/en unknown
-
2011
- 2011-04-26 US US13/094,155 patent/US8444998B2/en not_active Expired - Fee Related
-
2017
- 2017-02-16 IL IL250634A patent/IL250634A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
IL250634A0 (en) | 2017-03-30 |
AU2007266675B2 (en) | 2012-09-06 |
EA017558B1 (ru) | 2013-01-30 |
JP2009538614A (ja) | 2009-11-12 |
US7951385B2 (en) | 2011-05-31 |
EP2021457A2 (en) | 2009-02-11 |
US8444998B2 (en) | 2013-05-21 |
WO2007138538A2 (en) | 2007-12-06 |
EA200802409A1 (ru) | 2009-10-30 |
AP2008004626A0 (en) | 2008-10-31 |
AU2007266675A1 (en) | 2007-12-06 |
KR101521123B1 (ko) | 2015-05-19 |
EP2021457B1 (en) | 2015-02-11 |
IL195520A0 (en) | 2011-08-01 |
CA2647161A1 (en) | 2007-12-06 |
US20110268703A1 (en) | 2011-11-03 |
NZ571619A (en) | 2011-10-28 |
KR20090023626A (ko) | 2009-03-05 |
CN101454440A (zh) | 2009-06-10 |
US20090297482A1 (en) | 2009-12-03 |
AP2841A (en) | 2014-02-28 |
WO2007138538A3 (en) | 2008-04-17 |
CN101454440B (zh) | 2013-05-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20084577L (no) | Probiotisk stamme og antimikrobielle peptider fra disse | |
Shih et al. | Selective production and characterization of levan by Bacillus subtilis (Natto) Takahashi | |
Vidhyalakshmi et al. | Bacillus circulans exopolysaccharide: Production, characterization and bioactivities | |
CL2018000537A1 (es) | Anticuerpo anti-factor d del complemento; polinucleótido codificante; vector que comprende dicho polinucleótido; célula húesped que comprende dicho vector; método de fabricación de anticuerpo; composición farmacéutica que lo comprende; uso del anticuerpo para tratar trastornos inflamatorios o trastornos oculares (divisional de cl 1001-2009). | |
WO2010093627A3 (en) | Fibronectin type iii domain based scaffold compositions, methods and uses | |
BRPI0606803A2 (pt) | axmi-018, axmi-020 e axmi-021, uma famìlia de genes de delta-endotoxina e métodos para seu uso | |
AR061467A1 (es) | Axmi-031 axmi-039 axmi-040 y axmi-049 una familia de nuevos genes de delta-endotoxinas y metodos para usarlos | |
MX348360B (es) | Anticuerpo biespecifico psmaxcd3 de simple cadena especifico de especies cruzadas. | |
BRPI0817911B8 (pt) | Processos para transferência de substâncias moleculares para dentro de células vegetais e processo para expressão de um gene | |
MX2009010610A (es) | Dominio de enlace especifico de especies cruzadas. | |
NO20080745L (no) | Nye peptider for anvendelse i behandling av fedme | |
NO20062662L (no) | Muteiner av fibroblast vekstfaktor 21 | |
MX2009011198A (es) | Peliculas que comprenden una pluralidad de polimeros. | |
WO2011137319A3 (en) | Stabilized fibronectin domain compositions, methods and uses | |
NZ597129A (en) | Hmo synthesis | |
AU2010321223A1 (en) | Process for the production of fine chemicals | |
TN2009000190A1 (en) | Lingo binding molecules and pharmaceutical use thereof | |
BR112012033703A2 (pt) | polipeptídeo tendo atividade beta-glicosidase e seus usos | |
JP2007175057A5 (no) | ||
DE602007008360D1 (de) | Aviäre telomerase reverse transkriptase | |
BRPI0516946A (pt) | enzimas lacase e seus usos | |
AR068428A1 (es) | Secuencias peptidicas y composiciones que las comprenden que proveen proteccion contra enfermedades transmitidas por artropodos | |
Lee et al. | Why?–Successful Pseudomonas aeruginosa clones with a focus on clone C | |
BRPI0507613A (pt) | expressão de plasminogênio e microplasminogênio em lentilha d'água | |
BR0309570A (pt) | Fatores camp quiméricos para vacinação contra infecção por streptococcus |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
CHAD | Change of the owner's name or address (par. 44 patent law, par. patentforskriften) |
Owner name: CIPLA-MEDPRO (PTY) LTD., ZA |
|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |